Home > Insider Trading > Filing (0001438133-20-000102)

Filing Details

Accession Number:: 0001438133-20-000102
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-07-02 18:19:22
Reporting Period:: 2020-06-30

Accepted Time:: 2020-07-02 18:19:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1438133	Tandem Diabetes Care Inc	TNDM	Surgical & Medical Instruments & Apparatus (3841)	204327508

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1726322	Leigh Vosseller	C/O Tandem Diabetes Care, Inc. 11075 Roselle Street San Diego CA 92121	Evp & Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-06-30	10,000	$2.59	14,520	No	4	M	Direct
Common Stock	Disposition	2020-06-30	10,000	$95.04	4,520	No	4	S	Direct
Common Stock	Acquisiton	2020-07-02	8,262	$9.00	12,782	No	4	M	Direct
Common Stock	Disposition	2020-07-02	8,262	$100.29	4,520	No	4	S	Direct
Common Stock	Acquisiton	2020-07-02	1,738	$18.86	6,258	No	4	M	Direct
Common Stock	Disposition	2020-07-02	1,738	$101.13	4,520	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2020-06-30	10,000	$0.00	10,000	$2.59
Common Stock	Common Stock	Disposition	2020-07-02	5,160	$0.00	5,160	$9.00
Common Stock	Common Stock	Disposition	2020-07-02	4,840	$0.00	4,840	$18.86

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	No	4	M	Direct
2,340	No	4	M	Direct
95,160	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	145	Indirect	Leigh A. Vosseller Trust

Footnotes

Represents shares of common stock received upon exercise of a stock option award.
The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2020.
The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $95.00 to $95.41. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $100.00 to $100.95. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $101.00 to $101.21. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
The securities are held by the Leigh A. Vosseller Trust dated January 17, 2010, of which Leigh Vosseller is the Trustee.
The option vested as to fifty percent (50%) of the underlying shares on 12/01/2018, and the remaining shares vested in twelve (12) equal monthly installments thereafter.
The expiration date for these options is 10 years from the date of grant.
The option vested as to twenty-five percent (25%) of the underlying shares on 05/17/2018, and the remaining shares shall vest in thiry-six (36) equal monthly installments thereafter.
The option vested as to fifty percent (50%) of the underlying shares on 06/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter.